Laura E. Raffals

520 total citations
18 papers, 363 citations indexed

About

Laura E. Raffals is a scholar working on Genetics, Epidemiology and Oncology. According to data from OpenAlex, Laura E. Raffals has authored 18 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Laura E. Raffals's work include Inflammatory Bowel Disease (8 papers), Microscopic Colitis (7 papers) and Colorectal Cancer Treatments and Studies (3 papers). Laura E. Raffals is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Microscopic Colitis (7 papers) and Colorectal Cancer Treatments and Studies (3 papers). Laura E. Raffals collaborates with scholars based in United States, Canada and Russia. Laura E. Raffals's co-authors include Sahil Khanna, Amy L. Lightner, Edward V. Loftus, John H. Pembérton, Kellie L. Mathis, Robert R. Cima, Chung Sang Tse, Eric J. Dozois, William A. Faubion and Kevin P. Quinn and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Mayo Clinic Proceedings.

In The Last Decade

Laura E. Raffals

17 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura E. Raffals United States 9 203 160 137 107 77 18 363
Lorena Rodríguez‐Alonso Spain 10 245 1.2× 237 1.5× 185 1.4× 100 0.9× 28 0.4× 27 421
Laurie B. Grossberg United States 8 194 1.0× 135 0.8× 67 0.5× 147 1.4× 26 0.3× 20 317
Javaid Subhani United Kingdom 6 305 1.5× 211 1.3× 101 0.7× 58 0.5× 75 1.0× 12 466
Takahiko Toyonaga Japan 13 253 1.2× 230 1.4× 104 0.8× 44 0.4× 40 0.5× 30 438
A Fernández-Clotet Spain 11 342 1.7× 239 1.5× 183 1.3× 71 0.7× 32 0.4× 27 435
Ottaviano Tarantino Italy 6 261 1.3× 222 1.4× 134 1.0× 78 0.7× 41 0.5× 8 378
Sara El Ouali United States 10 163 0.8× 94 0.6× 177 1.3× 40 0.4× 107 1.4× 20 326
Andre M. Van Gossum Belgium 5 297 1.5× 234 1.5× 106 0.8× 33 0.3× 76 1.0× 12 379
Asuka Nakarai Japan 11 406 2.0× 356 2.2× 231 1.7× 98 0.9× 32 0.4× 28 507
Justin Côté-Daigneault Canada 9 132 0.7× 141 0.9× 96 0.7× 30 0.3× 43 0.6× 17 311

Countries citing papers authored by Laura E. Raffals

Since Specialization
Citations

This map shows the geographic impact of Laura E. Raffals's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Raffals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Raffals more than expected).

Fields of papers citing papers by Laura E. Raffals

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Raffals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Raffals. The network helps show where Laura E. Raffals may publish in the future.

Co-authorship network of co-authors of Laura E. Raffals

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Raffals. A scholar is included among the top collaborators of Laura E. Raffals based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Raffals. Laura E. Raffals is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Croghan, Ivana T., Shaji Kumar, Sagar B. Dugani, et al.. (2024). Writing Groups for Healthcare Professionals in Academic Medicine. Journal of Primary Care & Community Health. 15. 4287886262–4287886262.
2.
Loftus, Edward V., Eric C. Ehman, Austin Todd, et al.. (2024). Differentiating clinical characteristics of perianal inflammatory bowel disease from perianal hidradenitis suppurativa. International Journal of Dermatology. 64(3). 520–530. 2 indexed citations
3.
Vinsard, Daniela Guerrero, et al.. (2023). Development of an artificial intelligence tool for detecting colorectal lesions in inflammatory bowel disease. PubMed. 2(2). 91–101.e6. 24 indexed citations
4.
Dunleavy, Katie A., et al.. (2023). Causes, Diagnostic Testing, and Treatment of Residual Symptoms in Patients With IBD With Quiescent Disease. The American Journal of Gastroenterology. 118(11). 1909–1914. 2 indexed citations
5.
Cleveland, Noa Krugliak, Brian Bressler, Corey A. Siegel, et al.. (2022). A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities. Gastroenterology. 163(6). 1505–1509. 6 indexed citations
6.
Vinsard, Daniela Guerrero, James E. East, Sunanda V. Kane, et al.. (2022). Interobserver agreement of the modified Paris classification and histology prediction of colorectal lesions in patients with inflammatory bowel disease. Gastrointestinal Endoscopy. 97(4). 790–798.e2. 6 indexed citations
7.
Ebbert, Jon O., et al.. (2022). A 2030 Vision for the Mayo Clinic Department of Medicine. Mayo Clinic Proceedings. 97(7). 1232–1236. 3 indexed citations
8.
Raffals, Laura E., et al.. (2022). Management of Acute and Chronic Pouchitis. Diseases of the Colon & Rectum. 65(S1). S69–S76. 12 indexed citations
9.
Rajan, Elizabeth, Manuel Martı́nez, Emmanuel C. Gorospe, et al.. (2019). Prospective multicenter study to evaluate capsule endoscopy competency using a validated assessment tool. Gastrointestinal Endoscopy. 91(5). 1140–1145. 8 indexed citations
10.
Hansel, Stephanie L., Jeffrey D. McCurdy, John M. Barlow, et al.. (2018). Clinical Benefit of Capsule Endoscopy in Crohn’s Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement. Inflammatory Bowel Diseases. 24(7). 1582–1588. 27 indexed citations
11.
Quinn, Kevin P., Amy L. Lightner, William A. Faubion, & Laura E. Raffals. (2018). A Comprehensive Approach to Pouch Disorders. Inflammatory Bowel Diseases. 25(3). 460–471. 30 indexed citations
12.
Chedid, Victor, et al.. (2018). P100 RITUXIMAB-INDUCED COLITIS: THE MAYO CLINIC EXPERIENCE. Gastroenterology. 154(1). S51–S51. 1 indexed citations
13.
Khanna, Sahil & Laura E. Raffals. (2017). The Microbiome in Crohn's Disease. Gastroenterology Clinics of North America. 46(3). 481–492. 48 indexed citations
14.
Lightner, Amy L., et al.. (2017). Crohn’s Disease of the Pouch: A True Diagnosis or an Oversubscribed Diagnosis of Exclusion?. Diseases of the Colon & Rectum. 60(11). 1201–1208. 31 indexed citations
15.
Kottschade, Lisa A., Tobias Peikert, Mabel Ryder, et al.. (2016). A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy. Melanoma Research. 26(5). 469–480. 23 indexed citations
16.
Lightner, Amy L., Laura E. Raffals, Kellie L. Mathis, et al.. (2016). Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 11(2). 185–190. 101 indexed citations
17.
Felice, Kara M. De, Arjun Gupta, Sagar Rakshit, et al.. (2015). Ipilimumab-induced colitis in patients with metastatic melanoma. Melanoma Research. 25(4). 321–327. 37 indexed citations
18.
Raffals, Laura E., et al.. (2013). P-009 YI High Dose Budesonide in Steroid Refractory Ipilimumab-induced Colitis. Inflammatory Bowel Diseases. 19. S26–S27. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026